BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6193593)

  • 1. Activation of chemotactic factors in serum and wound fluid by dextranomer.
    Oredsson SU; Gottrup F; Beckmann A; Hohn DC
    Surgery; 1983 Sep; 94(3):453-7. PubMed ID: 6193593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotactic factor production by rat polymorphonuclear leukocytes: stimulation with opsonized zymosan particles and inhibition by dexamethasone.
    Kurihara A; Ojima F; Tsurufuji S
    Biochem Biophys Res Commun; 1984 Mar; 119(2):720-5. PubMed ID: 6712653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphonuclear granulocyte chemotaxis and chemotactic factor generation by concanavalin A-stimulated peripheral blood mononuclear cells in patients with psoriasis.
    Csató M; Dobozy A; Hunyadi J; Kenderessy SA; Simon N
    Arch Dermatol Res; 1981; 271(3):259-64. PubMed ID: 7305440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of chemotactic factor generation in human sera.
    Tannous R; Cavender N
    J Immunol Methods; 1980; 36(3-4):349-58. PubMed ID: 7430657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil chemotaxis under agarose: a statistical analysis and comparison of the chemotactic response of cells from different donors.
    Repo H; Leirisalo M; Kosunen TU
    J Immunol Methods; 1981; 46(2):227-42. PubMed ID: 7310132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis.
    Matzner Y; Marx G; Drexler R; Eldor A
    Thromb Haemost; 1984 Oct; 52(2):134-7. PubMed ID: 6084320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic factors for bovine leukocytes.
    Carroll EJ; Mueller R; Panico L
    Am J Vet Res; 1982 Sep; 43(9):1661-4. PubMed ID: 6816108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris.
    Knop J; Bossecker T; Kövary PM
    Arch Dermatol Res; 1982; 274(3-4):267-75. PubMed ID: 6219635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy.
    Esterly NB; Koransky JS; Furey NL; Trevisan M
    Arch Dermatol; 1984 Oct; 120(10):1308-13. PubMed ID: 6237616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
    Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
    J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphonuclear leukocyte chemotaxis by mixed anaerobic and aerobic bacteria.
    Namavar F; Verweij-Van Vught AM; Vel WA; Bal M; MacLaren DM
    J Med Microbiol; 1984 Oct; 18(2):167-72. PubMed ID: 6387126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokinetic and chemotactic factors in psoriasis scale extracts.
    Dahl MV; Lindroos WE; Nelson RD
    J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chemotactic inhibitor in synovial fluid.
    Matzner Y; Partridge RE; Babior BM
    Immunology; 1983 May; 49(1):131-8. PubMed ID: 6840801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered neutrophil migration during bacterial infection associated with a serum modulator of cellular motility.
    Link AS; Bass DA; McCall CE
    J Infect Dis; 1979 Oct; 140(4):517-26. PubMed ID: 512415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the alternative complement pathway and generation of stimulating factors for granulocytes by glass fibers.
    Governa M; Valentino M; Visona I; Marchiseppe I; Lo Martire N
    Cell Biol Toxicol; 1988 Jun; 4(2):187-97. PubMed ID: 2852993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotactic requirements of bovine leukocytes.
    Gray GD; Knight KA; Nelson RD; Herron MJ
    Am J Vet Res; 1982 May; 43(5):757-9. PubMed ID: 6283962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal chemotactic migration of polymorphonuclear leukocytes stimulated with mononuclear-derived chemotactic factor in ulcerative colitis.
    Hermanowicz A; Nawarska Z
    Int Arch Allergy Appl Immunol; 1986; 81(1):63-8. PubMed ID: 3744579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.
    Lundin A; Håkansson L; Michaëlsson G; Venge P
    Arch Dermatol Res; 1987; 279(6):385-91. PubMed ID: 3674962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
    Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
    Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.